-
Product Insights
NewLikelihood of Approval Analysis for Adrenal Gland Disorders
Overview How likely is it that the drugs in Adrenal Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenal Gland Disorders Overview Adrenal gland disorders comprise various conditions impacting...
-
Product Insights
NewLikelihood of Approval Analysis for Venous Thromboembolism
Overview How likely is it that the drugs in Venous Thromboembolism will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venous Thromboembolism Overview Venous thromboembolism (VTE) is a condition that occurs when...
-
Product Insights
NewLikelihood of Approval Analysis for Secondary Progressive Multiple Sclerosis (SPMS)
Overview How likely is it that the drugs in Secondary Progressive Multiple Sclerosis (SPMS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Secondary Progressive Multiple Sclerosis (SPMS) Overview Secondary progressive multiple...
-
Product Insights
NewLikelihood of Approval Analysis for Stroke
Overview How likely is it that the drugs in Stroke will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stroke Overview A stroke, also known as a cerebrovascular accident (CVA), is a...
-
Product Insights
NewLikelihood of Approval Analysis for Mycosis Fungoides
Overview How likely is it that the drugs in Mycosis Fungoides will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mycosis Fungoides Overview Mycosis fungoides is a rare type of non-Hodgkin lymphoma,...
-
Product Insights
NewLikelihood of Approval Analysis for Choroidal Disease
Overview How likely is it that the drugs in Choroidal Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Choroidal Disease Overview Choroidal dystrophy is an eye disorder that involves a...
-
Product Insights
NewLikelihood of Approval Analysis for Cerebrovascular Disease
Overview How likely is it that the drugs in Cerebrovascular Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cerebrovascular Disease Overview Cerebrovascular disease refers to a group of conditions that...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Biliary Tract Cancer
Overview How likely is it that the drugs in Metastatic Biliary Tract Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Biliary Tract Cancer Overview Metastatic biliary tract cancer, originating...
-
Product Insights
NewLikelihood of Approval Analysis for Neuroblastoma
Overview How likely is it that the drugs in Neuroblastoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neuroblastoma Overview Neuroblastoma is the cancer of the nerve tissues and neural crest...
-
Product Insights
NewLikelihood of Approval Analysis for Malignant Fibrous Histiocytoma of Soft Tissue
Overview How likely is it that the drugs in Malignant Fibrous Histiocytoma of Soft Tissue will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Fibrous Histiocytoma of Soft Tissue Overview Malignant...